A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
Clinical trial NCT03053427 · COMPLETED
Trial details
- NCT number
- NCT03053427
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2018-06-25
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.